127
Views
5
CrossRef citations to date
0
Altmetric
Review

Therapeutic options for Progressive Supranuclear Palsy including investigational drugs

ORCID Icon &
Pages 575-587 | Received 16 Mar 2017, Accepted 24 May 2017, Published online: 12 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ali Shoeibi, Nahid Olfati & Irene Litvan. (2018) Preclinical, phase I, and phase II investigational clinical trials for treatment of progressive supranuclear palsy. Expert Opinion on Investigational Drugs 27:4, pages 349-361.
Read now

Articles from other publishers (4)

Lawren VandeVrede, Peter A. Ljubenkov, Julio C. Rojas, Ariane E. Welch & Adam L. Boxer. (2020) Four-Repeat Tauopathies: Current Management and Future Treatments. Neurotherapeutics 17:4, pages 1563-1581.
Crossref
Lawren VandeVrede, Marian L. Dale, Scott Fields, Megan Frank, Emma Hare, Hilary W. Heuer, Kellie Keith, Mary Koestler, Peter A. Ljubenkov, Dana McDermott, Noelle Ohanesian, Jennifer Richards, Julio C. Rojas, Elisabeth H. Thijssen, Christine Walsh, Ping Wang, Amy Wolf, Joseph F. Quinn, Richard Tsai & Adam L. Boxer. (2020) Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy . Movement Disorders Clinical Practice 7:4, pages 440-447.
Crossref
Ali Shoeibi, Nahid Olfati & Irene Litvan. (2019) Frontrunner in Translation: Progressive Supranuclear Palsy. Frontiers in Neurology 10.
Crossref
Nahid Olfati, Ali Shoeibi & Irene Litvan. (2019) Progress in the treatment of Parkinson-Plus syndromes. Parkinsonism & Related Disorders 59, pages 101-110.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.